FCM analysis indicated that CTH and CD86 expression in macrophages cultured with serum derived from patients with BC was significantly decreased compared to that in macrophages cultured with serum derived from healthy donors, whereas CD206 expression was increased (P < 0.001, Figure 1J; Figure S1E, Supporting Information). This evidence concerns the gene CD86 and breast cancer.